(Q40179021)

18 September 2017

1 reference

title

Preclinical pharmacology and toxicology of estramustine phosphate (English)

1 reference

18 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

11 October 2023

author name string

Jonas Müntzing

1

0 references

K. Gunnarsson

2

0 references

J. Müntzing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6375082

11 October 2023

language of work or name

English

0 references

publication date

1 June 1984

1 reference

full work available at URL

18 September 2017

June 1984

0 references

https://api.elsevier.com/content/article/PII:S0090429584800916?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

https://api.elsevier.com/content/article/PII:S0090429584800916?httpAccept=text/plain

11 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

11 October 2023

1 reference

18 September 2017

volume

23

1 reference

18 September 2017

issue

6 Suppl

1 reference

18 September 2017

6

0 references

page(s)

6-10

1 reference

Effect of estramustine phosphate (Estracyt) on transplantable mouse tumours

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Human prostatic adenocarcinoma: comparative experimental treatment of the tumor line PC 82 in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Studies of Antiprostatic Agents in the Baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

Effects of estramustine and megestrol on ultrastructure of rat ventral prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

The mutagenic activity of anti-cancer drugs and the urine of rats given these drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2884%2980091-6

7 January 2021

A rat prostatic adenocarcinoma as a model for the human disease

5

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

Transplantable metastasizing prostate adenocarcinomas in rats

11 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol

11 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

Potential test systems for chemotherapeutic agents against prostatic cancer

11 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

Histochemical and ultrastructural study of prostatic tissue from baboons treated with antiprostatic drugs

11 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

Effect of estracyt on the rat prostate

11 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

A lipofuscin-like pigment in the kidneys of estrogen-treated rats

11 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(84)80091-6

11 October 2023

Identifiers

0 references

1 reference